Apontis Pharma AG (ETR:APPH)

Market Cap	92.88M
Revenue (ttm)	48.47M
Net Income (ttm)	753.57K
Shares Out	8.33M
EPS (ttm)	0.09
PE Ratio	123.25
Forward PE	26.87
Dividend	n/a
Ex-Dividend Date	n/a

Volume	50
Average Volume	1,141
Open	11.55
Previous Close	11.15
Day's Range	11.55 - 11.55
52-Week Range	6.30 - 12.35
Beta	1.24
RSI	57.60
Earnings Date	Mar 28, 2025

About Apontis Pharma AG

Apontis Pharma AG engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany. It offers single pills and other pharmaceutical products with a focus on cardiovascular diseases, such as hypertension, hyperlipidemia, and secondary prophylaxis, as well as respiratory diseases and diabetes. The company was founded in 1946 and is based in Monheim am Rhein, Germany. As of November 21, 2024, Apontis Pharma AG operates as a subsidiary of Zentiva AG.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1946
• Employees: 137
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: APPH